Atlas Trials

RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension

Clinical trial NCT01756300 · COMPLETED

Trial details

NCT number
NCT01756300
Sponsor
Biosense Webster, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypertension, Renal
Start date
2012-12-01
Primary completion
2013-11-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.